We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+11.02%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$198M
AUM Growth
+$37.9M
Cap. Flow
+$42.3M
Cap. Flow %
21.36%
Top 10 Hldgs %
27.74%
Holding
86
New
20
Increased
29
Reduced
15
Closed
16

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$3.35M
2
AMGN icon
Amgen
AMGN
+$3.08M
3
CVS icon
CVS Health
CVS
+$2.6M
4
BSX icon
Boston Scientific
BSX
+$2.39M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.1M

Sector Composition

Rank Sector Weight
1 Healthcare 88.23%
2 Financials 0%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYH icon
1
Community Health Systems
CYH
$382M
$6.35M 3.21%
169,400
-11,773
-6% -$392K
THC icon
2
Tenet Healthcare
THC
$22.2B
$5.87M 2.96%
125,000
+7,280
+6% +$329K
UHS icon
3
Universal Health Services
UHS
$10.2B
$5.75M 2.9%
60,000
-5,000
-8% -$432K
HCA icon
4
HCA Healthcare
HCA
$88.4B
$5.64M 2.85%
100,000
+11,090
+12% +$585K
MCK icon
5
McKesson
MCK
$104B
$5.59M 2.82%
30,000
+10,160
+51% +$1.81M
COR icon
6
Cencora
COR
$62B
$5.45M 2.75%
75,000
+25,350
+51% +$1.74M
LPNT
7
DELISTED
LifePoint Health, Inc.
LPNT
$5.2M 2.62%
83,660
-200
-0.2% -$11.7K
CAH icon
8
Cardinal Health
CAH
$53.7B
$5.14M 2.6%
75,000
+35,000
+88% +$2.38M
RAD
9
DELISTED
Rite Aid Corporation
RAD
$5.02M 2.53%
35,000
+10,000
+40% +$1.48M
COV
10
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$4.96M 2.5%
55,000
+25,000
+83% +$1.87M
ELV icon
11
Elevance Health
ELV
$81.5B
$4.84M 2.44%
45,000
+10,330
+30% +$1.06M
ABBV icon
12
AbbVie
ABBV
$465B
$4.8M 2.42%
85,000
+26,640
+46% +$1.4M
SHPG
13
DELISTED
Shire pic
SHPG
$4.71M 2.38%
+20,000
New +$3.48M
ZBH icon
14
Zimmer Biomet
ZBH
$18.8B
$4.67M 2.36%
46,350
+11,021
+31% +$1.08M
CNC icon
15
Centene
CNC
$30.5B
$4.54M 2.29%
240,000
-18,160
-7% -$312K
AGN
16
DELISTED
Allergan plc
AGN
$4.46M 2.25%
20,000
+10,000
+100% +$2.07M
MOH icon
17
Molina Healthcare
MOH
$10.4B
$4.33M 2.18%
96,921
+7,581
+8% +$307K
DGX icon
18
Quest Diagnostics
DGX
$26B
$4.3M 2.17%
73,200
+34,668
+90% +$2.03M
AGN
19
DELISTED
Allergan Inc
AGN
$4.23M 2.14%
25,000
+240
+1% +$37.4K
LH icon
20
Labcorp
LH
$25.2B
$4.1M 2.07%
46,560
+11,640
+33% +$1.01M
EVHC
21
DELISTED
Envision Healthcare Holdings Inc
EVHC
$4.04M 2.04%
37,542
+10,822
+41% +$1.11M
SNN icon
22
Smith & Nephew
SNN
$13.7B
$4.02M 2.03%
112,500
VTRS icon
23
Viatris
VTRS
$20.8B
$3.87M 1.95%
75,000
+20,000
+36% +$983K
WBA
24
DELISTED
Walgreens Boots Alliance
WBA
$3.71M 1.87%
50,000
+790
+2% +$55.2K
MNK
25
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$3.6M 1.82%
45,000
+15,490
+52% +$1.12M

Similar funds

Sivik Global Healthcare's Q2 2014 Portfolio in Review

As of Q2 2014, Sivik Global Healthcare held 86 positions worth $198M, up 24% from $160M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Sivik Global Healthcare deployed $42.3M of net new capital in Q2 2014, opening 20 new positions and adding to 29 existing holdings. Its largest new stake was Shire pic: 20,000 shares worth $4.71M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 89% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Celgene Corp, an estimated $1.84M trimmed.

  • Sivik Global Healthcare's largest Q2 2014 buy was Shire pic: 20,000 shares worth $4.71M.
  • Sivik Global Healthcare added most to Cardinal Health in Q2 2014, an estimated $2.38M increase.
  • Sivik Global Healthcare's biggest Q2 2014 reduction was Celgene Corp, cutting an estimated $1.84M.
  • Sivik Global Healthcare fully exited Aetna Inc in Q2 2014, selling an estimated $3.35M.
  • Sivik Global Healthcare's ten largest holdings make up 28% of its $198M portfolio in Q2 2014.
  • Sivik Global Healthcare opened 20 new positions and closed 16 in Q2 2014.
  • Sivik Global Healthcare's portfolio value rose 24% quarter-over-quarter to $198M.

Based on Sivik Global Healthcare's 13F filing for Q2 2014, filed 3 Jul 2014.